Skip to main content
Clinical Trials/ACTRN12616000606482
ACTRN12616000606482
Completed
未知

Comparing functional measures and blood loss with the of tranexamic acid in patients undergoing elective anterior total hip arthroplasty. A Randomized controlled trial.

Dr Andrew Fraval0 sites100 target enrollmentMay 10, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Andrew Fraval
Enrollment
100
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 10, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Andrew Fraval

Eligibility Criteria

Inclusion Criteria

  • Eligible participants will be adults aged 40 or above undergoing a total hip replacement in the private practice of Mr Phong Tran.

Exclusion Criteria

  • Exclusion criteria are:
  • Contraindication to tranexamic acid use:
  • \- Allergies or previously known drug reaction to tranexamic acid,
  • \- Active intravascular clotting – DVT, PE or cerebral thrombosis
  • \- Predisposition to thrombosis – previous documented DVT or PE
  • \- Subarachnoid hemorrhage
  • Rheumatoid arthritis

Outcomes

Primary Outcomes

Not specified

Similar Trials